... Temserolimus was FDA approved for the treatment of advanced renal cell carcinoma in 2007 and is currently being evaluated in several clinical trials for its use in the treatment of gynecologic malignancies, including ovarian carcinoma.[28] Cell culture studies [10,293031 and mouse models323334353637 also suggested that PI3K pathway inhibitors are efficient in suppressing ovarian cancer cell growth. We analyzed the effect of the PI3K, AKT and mTORC1 inhibitors LY294002, SH-6 and rapamycin, respectively, on ovarian cancer cell growth using established cell lines and fresh human tumor tissue. ...


Shanghai Advanced Institute of Finance The Shanghai Advanced Institute of Finance (SAIF) was established by the Shanghai Municipal Government at Shanghai Jiao Tong University in April 2009. Its mission is to become a world class institute of research and higher learning with world class faculty. SAIF is committed to developing top talents for the financial world and to generate cutting-edge knowledge in financial theories and applications. As a member of Shanghai's financial community, it strives to contribute to the development of Shanghai as a global financial center.

To study the expression of VEGF, KDR, MMP-1, and its transcription factor Ets-1 on the interstitial neovasculogenesis in human cervical carcinoma on molecular level, which may provide further theoretic bases on judgement of prognosis and explain interregularity between neovasculagenetic factors. VEGF, KDR, MMP-1, and Ets-1 were detected in 87 cervi...

×